Today: 19 May 2026
Browse Category

NASDAQ:SWKS 28 October 2025 - 26 January 2026

Skyworks Soars 18% on $22B Qorvo Merger – What’s Next for the Chipmaker?

Skyworks Soars 18% on $22B Qorvo Merger – What’s Next for the Chipmaker?

Skyworks shares jumped nearly 18% to around $89 on Oct. 28 after announcing a $22 billion cash-and-stock deal to acquire Qorvo. Qorvo holders will receive $32.50 and 0.96 Skyworks shares per Qorvo share. Skyworks recently reported Q3 revenue of $965 million and non-GAAP EPS of $1.33, both above forecasts. Wall Street remains cautious, with an average 12-month target of $70.90.
28 October 2025
···

Stock Market Today

  • Western Digital Leverages Post-Quantum Cryptography to Enhance AI Data Security
    May 19, 2026, 9:57 AM EDT. Western Digital Corporation (WDC) integrates post-quantum cryptography (PQC) into its Ultrastar UltraSMR hard drives to address future AI data security risks. The drives, undergoing qualification with hyperscale customers, embed PQC directly into storage firmware, enhancing protection against quantum-era threats by ensuring firmware integrity and secure key management. Using NIST-aligned ML-DSA-87 and RSA-3072 algorithms, WDC advances device-level trust with dual-signing strategies. This positions WDC ahead in quantum-resistant enterprise storage security. Competitor Seagate Technology (STX) continues focusing on durable, cost-efficient storage solutions amid rising AI data demands, while WDC's split into SanDisk aims to capitalize further on AI-driven markets.

Latest articles

Bakkt Up Early After Director Buys $4.85M in Shares

Bakkt Up Early After Director Buys $4.85M in Shares

19 May 2026
Bakkt shares jumped 14.2% to $9.96 in pre-market trading Tuesday after a filing showed director Michael Alfred’s vehicle bought $4.85 million in stock. SEC documents said Alfred acquired 585,000 shares last week via Alpine Fox LP. CEO Akshay Naheta exercised options for 33,557 shares at $10 each. Bakkt recently reported Q1 revenue of $243.6 million, down sharply from a year earlier.
Relay Therapeutics Shares Rise In Pre-Market Ahead Of Key Drug Update

Relay Therapeutics Shares Rise In Pre-Market Ahead Of Key Drug Update

19 May 2026
Relay Therapeutics shares jumped 11.3% to $13.47 in premarket trading Tuesday after reporting a 60% volumetric response rate in 20 evaluable patients from its Phase 2 trial of zovegalisib for vascular anomalies. The company said 95% of patients saw some lesion reduction at 12 weeks. No patients discontinued due to adverse events. The regular Nasdaq session was set to open at 9:30 a.m. ET.

Popular

NextEra shares dip after $66.8B Dominion deal—What’s on traders’ radar now

NextEra shares dip after $66.8B Dominion deal—What’s on traders’ radar now

19 May 2026
NextEra Energy shares fell 4.6% to $89.04 late Monday after announcing a $66.8 billion stock-led merger with Dominion Energy, whose shares rose 9.4% to $67.56. The deal would create one of the world’s largest electric utilities, serving about 10 million customer accounts and owning 110 gigawatts of generation across four states.
Go toTop